Three independent discounted-cash-flow-style models value ResMed Inc. every trading day. 0 of 3 currently price RMD above its market price.
| Free Cash Flow model | $203.32 |
| Excess Profit model | $178.35 |
| Residual Earnings model | $79.41 |
| Dividend Discount model | $80.84 |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +20.3% |
| Net debt / EBITDA | -0.3× |
| Gross margin | +61.1% |
| Revenue CAGR | +10.2% |
| Cash conversion | 1.2× |
| Dividend yield | +1.2% |
| Buyback yield | +1.5% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open RMD in StockKitty